The present invention relates to the use of these compounds in the treatment of patients suffering from impairment of nerve or cognitive function due to deficiency of the number of excitatory synapses or AMPA receptors, /RTI The compounds of the present invention can also be used in non-compromised patients to enhance the ability of perceptual-motor and cognitive tasks dependent on the brain network using AMPA receptors and to improve memory encryption.
展开▼